STE · 8-K · 20260805PR053412

Products and Technology

STERIS plc · 2026-08-05 · Importance 49 · Surprise 32

Recurring products and services drove the company’s growth, with total consumables revenue increasing from $435.0 million to $474.0 million and service revenue increasing from $700.6 million to $755.5 million. Healthcare capital equipment revenue increased 1% to $230.5 million, while Applied Sterilization Technologies capital equipment revenue declined 13% and Life Sciences capital equipment revenue increased 17% to $31.3 million. Life Sciences consumables grew 8% and service revenue grew 2%, indicating stronger demand for both equipment and recurring offerings in that segment.